Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
6
×
deals
6
×
life sciences
national blog main
national top stories
6
×
san francisco blog main
vc
6
×
boston blog main
new york blog main
san diego blog main
san diego top stories
startups
boston top stories
new york top stories
san francisco top stories
cancer
gene therapy
ipo
venture capital
avalon ventures
correlation ventures
funding
hemophilia
innovation
laura shawver
medicxi
orbimed
ra capital management
san diego
san francisco
synthorx
acetylon pharmaceuticals
adeno-associated virus
administration
alexandria venture investments
altitude life science ventures
alzheimer's
ambys medicines
american society of gene and cell therapy
amgen
What
drugs
new
advance
biology
biotech
cytokine
enhanced
gene
medicines
san
startup
suite
synthetic
synthorx
therapy
today
aiming
aims
ambys
approach
based
becker
big
billions
bio
biologic
called
company
control
crude
cutting
deadly
deal
debuted
debuts
demonstrating
despite
developing
diego’s
diseases
Language
unset
Current search:
vc
×
deals
×
photo
×
biotech
×
" national top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs